Anatomy (ICA), population strata outcome, Population: PCI and CABG.Predicts MACCE prognosis from 1 to 5 years in the SYNTAX trial (PCI vs. CABG in three-vessel disease and left main)1-3 and mortality up to 10 years in the SYNTAXES study.
Anatomy (ICA) and comorbidity, Population: individualized outcome for “all-comers” PCI Predicts all-cause mortality at 2 years in “all-comers” PCI.
Anatomy (CTA), comorbidity, and functionality (FFRCT), Population: PCI and CABG Treatment decision making between PCI and CABG in 3VD & LM based solely on multi-slice CT scan with FFRCT in the SYNTAX III REVOLUTION trial.
Anatomy (ICA and CTA) and functionality (iFR, FFR, FFRCT, QFR), Population: PCI and CABG Treatment decision making based on anatomy and functionality.
Anatomy (ICA) and comorbidity, Population: PCI versus CABG. Predicts 4-year all-cause mortality in the SYNTAX trial.
* The SYNTAX Score II will be superseded by SYNTAX Score 2020.
Anatomy (CTA), comorbidity, and functionality (FFRCT), Population: CABG Planning and execution of surgery in 3VD & LM applying SYNTAX Score III erived solely on CTA scan with FFRCT (the FASTTRACK CABG trial, First in men).
Anatomy (ICA) and comorbidity, Population: PCI versus CABG Predict 5-year MACE and 10-year all-cause mortality based on cross validation in the SYNTAX trial and on external validation in the FREEDOM, BEST, and PRECOMBAT trials
**CABG: coronary artery bypass grafting; CTA: computed tomography angiography; FFR: fractional flow reserve; FFRCT: fractional flow reserve derived from CTA; ICA: invasive coronary angiography; iFR: instantaneous wave-free ratio; QFR: quantitative Flow Ratio; PCI: percutaneous coronary intervention; 3VD: three-vessel disease; LM: left main:.